Effects of vitamin D2
 or D3
 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial

N. G. Forouhi; R. K. Menon; S. J. Sharp; N. Mannan; P. M. Timms; A. R. Martineau; A. P. Rickard; B. J. Boucher; T. A. Chowdhury; C. J. Griffiths; S. E. Greenwald; S. J. Griffin; G. A. Hitman

doi:10.1111/dom.12625

Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12625 ◽

2016 ◽

Vol 18 (4) ◽

pp. 392-400 ◽

Cited By ~ 43

Author(s):

N. G. Forouhi ◽

R. K. Menon ◽

S. J. Sharp ◽

N. Mannan ◽

P. M. Timms ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Glycaemic Control ◽

Cardiometabolic Risk ◽

Controlled Trial ◽

Vitamin D2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effects of vitamin D2 or D3supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial

BMC Public Health ◽

10.1186/1471-2458-13-999 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 3

Author(s):

Ravi K Menon ◽

Anna P Rickard ◽

Nasima Mannan ◽

Peter M Timms ◽

Stephen J Sharp ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Glycaemic Control ◽

Controlled Trial ◽

Metabolic Parameters ◽

Vitamin D2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735542506.793559665 ◽

2019 ◽

Author(s):

Carmine Zoccali ◽

Davide Bolignano

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Download Full-text

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01434.x ◽

2011 ◽

Vol 13 (10) ◽

pp. 928-938 ◽

Cited By ~ 252

Author(s):

K. Strojek ◽

K. H. Yoon ◽

V. Hruba ◽

M. Elze ◽

A. M. Langkilde ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(19)30086-5 ◽

2019 ◽

Vol 7 (6) ◽

pp. 429-441 ◽

Cited By ~ 45

Author(s):

Carol Pollock ◽

Bergur Stefánsson ◽

Daniel Reyner ◽

Peter Rossing ◽

C David Sjöström ◽

...

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Download Full-text

Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial

Diabetologia ◽

10.1007/s00125-017-4289-0 ◽

2017 ◽

Vol 60 (8) ◽

pp. 1390-1399 ◽

Cited By ~ 29

Author(s):

Christoph Kapitza ◽

Kirsten Dahl ◽

Jacob B. Jacobsen ◽

Mads B. Axelsen ◽

Anne Flint

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(10)60407-2 ◽

2010 ◽

Vol 375 (9733) ◽

pp. 2223-2233 ◽

Cited By ~ 546

Author(s):

Clifford J Bailey ◽

Jorge L Gross ◽

Anne Pieters ◽

Arnaud Bastien ◽

James F List

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial

Journal of Herbal Medicine ◽

10.1016/j.hermed.2019.100315 ◽

2020 ◽

Vol 20 ◽

pp. 100315

Author(s):

Hasan Gholinezhad ◽

Hadi Bazyar ◽

Homeira Rashidi ◽

Parvin Salehi ◽

Mohammad Hosein Haghighi-zadeh ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Chronic Periodontitis ◽

Controlled Trial ◽

Periodontal Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double‐blind , placebo‐controlled clinical trial

Phytotherapy Research ◽

10.1002/ptr.6990 ◽

2021 ◽

Author(s):

Saeid Hadi ◽

Reza Daryabeygi‐Khotbehsara ◽

Parvin Mirmiran ◽

Jenna McVicar ◽

Vahid Hadi ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiometabolic Risk ◽

Nigella Sativa ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Oil Extract

Download Full-text

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ ◽

10.1136/bmj.328.7441.686-b ◽

2004 ◽

Vol 328 (7441) ◽

pp. 686.3

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Controlled Trial ◽

Urinary Albumin ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Outcomes

Download Full-text